GRAIL (GRAL) Competitors $75.52 +6.23 (+8.99%) Closing price 04:00 PM EasternExtended Trading$76.10 +0.58 (+0.77%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. GH, RDNT, BTSG, SHC, OPCH, WGS, HTFL, PRVA, VCYT, and SGRYShould you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Heartflow (HTFL), Privia Health Group (PRVA), Veracyte (VCYT), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. GRAIL vs. Its Competitors Guardant Health RadNet BrightSpring Health Services Sotera Health Option Care Health GeneDx Heartflow Privia Health Group Veracyte Surgery Partners GRAIL (NASDAQ:GRAL) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation and institutional ownership. Is GRAL or GH more profitable? Guardant Health has a net margin of -49.93% compared to GRAIL's net margin of -329.86%. Guardant Health's return on equity of 0.00% beat GRAIL's return on equity.Company Net Margins Return on Equity Return on Assets GRAIL-329.86% -16.64% -14.02% Guardant Health -49.93%N/A -28.95% Which has higher valuation & earnings, GRAL or GH? Guardant Health has higher revenue and earnings than GRAIL. Guardant Health is trading at a lower price-to-earnings ratio than GRAIL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGRAIL$125.60M21.76-$2.03B-$13.11-5.78Guardant Health$739.02M10.81-$436.37M-$3.35-19.13 Which has more volatility and risk, GRAL or GH? GRAIL has a beta of 4.11, suggesting that its stock price is 311% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500. Do analysts rate GRAL or GH? GRAIL presently has a consensus target price of $56.67, suggesting a potential downside of 25.25%. Guardant Health has a consensus target price of $65.86, suggesting a potential upside of 2.76%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts clearly believe Guardant Health is more favorable than GRAIL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GRAIL 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Guardant Health 1 Sell rating(s) 0 Hold rating(s) 23 Buy rating(s) 0 Strong Buy rating(s) 2.92 Does the media prefer GRAL or GH? In the previous week, Guardant Health had 3 more articles in the media than GRAIL. MarketBeat recorded 10 mentions for Guardant Health and 7 mentions for GRAIL. Guardant Health's average media sentiment score of 0.65 beat GRAIL's score of 0.65 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GRAIL 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of GRAL or GH? 92.6% of Guardant Health shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryGuardant Health beats GRAIL on 12 of the 16 factors compared between the two stocks. Get GRAIL News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGRAILMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.71B$3.40B$6.05B$10.51BDividend YieldN/A2.30%5.73%4.80%P/E Ratio-5.7423.0384.9327.30Price / Sales21.76268.08515.79197.96Price / Cash2.4446.9537.5761.53Price / Book1.0210.5412.426.82Net Income-$2.03B-$52.58M$3.32B$276.59M7 Day Performance4.15%0.59%0.53%0.00%1 Month Performance92.76%15.50%10.24%7.96%1 Year Performance441.13%18.01%75.92%35.10% GRAIL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGRAIL1.1642 of 5 stars$75.52+9.0%$56.67-25.0%+399.6%$2.72B$125.60M-5.761,360GHGuardant Health3.5681 of 5 stars$63.38+0.9%$65.75+3.7%+193.2%$7.84B$739.02M-18.922,021RDNTRadNet2.9633 of 5 stars$78.29+0.8%$76.80-1.9%+4.5%$5.97B$1.83B-391.4311,021Positive NewsBTSGBrightSpring Health Services2.6705 of 5 stars$28.87+1.8%$29.13+0.9%+95.7%$5.02B$11.27B93.1335,000News CoverageAnalyst ForecastGap UpSHCSotera Health2.7456 of 5 stars$16.22+1.7%$17.20+6.0%+3.8%$4.53B$1.10B202.783,000News CoverageOPCHOption Care Health4.8563 of 5 stars$27.33-0.6%$35.11+28.5%-11.4%$4.46B$5.00B21.868,088Positive NewsWGSGeneDx2.4304 of 5 stars$120.19+1.6%$104.13-13.4%+104.4%$3.40B$305.45M2,403.801,200News CoverageHTFLHeartflowN/A$37.28-1.0%$36.60-1.8%N/A$3.14BN/A0.00699Positive NewsPRVAPrivia Health Group3.5448 of 5 stars$24.13+0.2%$28.58+18.5%+39.7%$2.96B$1.74B219.381,140VCYTVeracyte3.5862 of 5 stars$36.04+0.1%$40.90+13.5%+0.1%$2.83B$445.76M109.22790SGRYSurgery Partners3.1787 of 5 stars$20.39-3.6%$31.43+54.1%-34.1%$2.71B$3.24B-14.2615,000 Related Companies and Tools Related Companies Guardant Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Option Care Health Alternatives GeneDx Alternatives Heartflow Alternatives Privia Health Group Alternatives Veracyte Alternatives Surgery Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRAIL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRAIL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
